Chicago, Illinois 60611


Purpose:

The purpose of this study is to test the effectiveness of an electronic health record based strategy in promoting safe use of opioid medications after an Emergency Department visit. The EHR-based strategy was designed to enhance provider counseling about opioids and to standardize and simplify the information that patients receive.


Study summary:

Research has shown that patients frequently leave the emergency department without sufficient knowledge about how to safely use their newly prescribed opioid pain relievers. Additionally, educational interventions have the ability to increase patient knowledge about medications. In this study, education interventions will be implemented at the level of the EHR and prompt increased provider counseling with a goal of improving patient knowledge and safe use of opioids after ED discharge. The investigators will conduct a three-arm provider randomized controlled trial among English-speaking adults prescribed hydrocodone-acetaminophen to evaluate the effectiveness of the EMC2 strategy, with and without SMS text reminders, to improve patient understanding and safe use of their medication compared to usual care. This study will be conducted at an urban, academic emergency department (annual volume >85,000 patient visits) in Chicago, IL. English speaking patients will be recruited and assessed in person at baseline, and by phone at 2-4 days, 7-14 days, and 1 month after recruitment.


Criteria:

Inclusion Criteria: - To be eligible to enroll and remain in the study, patient subjects must meet all of the following criteria: 1. Patient age 18 years and older 2. English language speaking 3. prescribed pill form of hydrocodone-acetaminophen opioid pain reliever 4. own a cell phone with text messaging capabilities 5. the patient is the person primarily responsible for administering medication Exclusion Criteria: - Subjects will be excluded from the study if any of the following conditions are met: 1. Aged <18 2. non-English speaking 3. clinically unstable, psychologically impaired or intoxicated as judged by research staff member or emergency physician 4. chronic opioid use, defined as daily or near daily use of opioid pain relievers for the past 90 days 5. admitted to hospital 6. unable to complete follow up phone interviews 7. pregnant


NCT ID:

NCT02431793


Primary Contact:

Principal Investigator
Danielle McCarthy, MD
Northwestern University Feinberg School of Medicine

Danielle McCarthy, MD
Phone: 312-694-7000
Email: d-mccarthy2@northwestern.edu


Backup Contact:

Email: megan.rowland@northwestern.edu
Megan Rowland, MPH
Phone: 312-926-8817


Location Contact:

Chicago, Illinois 60611
United States

Danielle McCarthy, MD MS
Phone: 312-694-7000
Email: d-mccarthy2@northwestern.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.